{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:32Z","timestamp":1786119272465,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/iae.0b013e318150d6f0","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T11:06:56Z","timestamp":1236251216000},"page":"S81-S86","source":"Crossref","is-referenced-by-count":12,"title":["HETEROGENEOUS TUMOR VASCULATURE IN RETINOBLASTOMA"],"prefix":"10.1097","volume":"28","author":[{"given":"MARIA-ELENA","family":"JOCKOVICH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOLANDA","family":"PI\u00d1A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARMANDO","family":"ALEGRET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"COLLEEN","family":"CEBULLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WILLIAM","family":"FEUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIMOTHY G.","family":"MURRAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210130","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications.","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01666825","article-title":"Anti-angiogenesis as a new concept for the therapy of neovascular diseases.","volume":"69","author":"Schweigerer","year":"1991","journal-title":"Klin Wochenschr"},{"key":"R3-16-20210130","first-page":"36","article-title":"Angiogenesis capacity as a diagnostic marker for human eye tumors.","volume":"86","author":"Tapper","year":"1979","journal-title":"Surgery"},{"key":"R4-16-20210130","first-page":"501","article-title":"Capillary endothelial cell migration: stimulating activity of aqueous humor from patients with ocular cancers.","volume":"71","author":"Tapper","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"R5-16-20210130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006982-198400430-00011","article-title":"Retinoblastoma and angiogenesis activity.","volume":"4","author":"Albert","year":"1984","journal-title":"Retina"},{"key":"R6-16-20210130","first-page":"2037","article-title":"Retinoblastoma. The relationship of proliferating cells to blood vessels.","volume":"31","author":"Burnier","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/bjo.87.10.1224","article-title":"Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.","volume":"87","author":"Marback","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jjo.2003.09.002","article-title":"Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters.","volume":"47","author":"Kerimogglu","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9440(10)63129-X","article-title":"Higher vessel densities in retinoblastoma with local invasive growth and metastasis.","volume":"164","author":"Rossler","year":"2004","journal-title":"Am J Pathol"},{"key":"R10-16-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ohc.2004.08.006","article-title":"Retinoblastoma: animal models.","volume":"18","author":"Conway","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R11-16-20210130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.04-0751","article-title":"Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.","volume":"46","author":"Escalona-Benz","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-16-20210130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1167\/iovs.05-1194","article-title":"Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.","volume":"47","author":"Jockovich","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-16-20210130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jnci\/94.12.883","article-title":"Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.","volume":"94","author":"Hlatky","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R14-16-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9440(10)63809-6","article-title":"Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.","volume":"162","author":"Gee","year":"2003","journal-title":"Am J Pathol"},{"key":"R15-16-20210130","first-page":"1388","article-title":"Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.","volume":"60","author":"Eberhard","year":"2000","journal-title":"Cancer Res"},{"key":"R16-16-20210130","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1167\/iovs.06-1397","article-title":"Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LHBETATAG Mouse Model.","volume":"48","author":"Jockovich","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-16-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8","article-title":"CD 105 and angiogenesis.","volume":"178","author":"Kumar","year":"1996","journal-title":"J Pathol"},{"key":"R18-16-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01680633","article-title":"Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues.","volume":"19","author":"Laitinen","year":"1987","journal-title":"Histochem J"},{"key":"R19-16-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI6127","article-title":"Blood vessel maturation: vascular development comes of age.","volume":"103","author":"Darland","year":"1999","journal-title":"J Clin Invest"},{"key":"R20-16-20210130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","article-title":"Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.","volume":"103","author":"Benjamin","year":"1999","journal-title":"J Clin Invest"},{"key":"R21-16-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-4800(70)90084-5","article-title":"Role of the pericyte in wound healing. An ultrastructural study.","volume":"13","author":"Crocker","year":"1970","journal-title":"Exp Mol Pathol"},{"key":"R22-16-20210130","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI200320087","article-title":"What brings pericytes to tumor vessels?","volume":"112","author":"Jain","year":"2003","journal-title":"J Clin Invest"},{"key":"R23-16-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance.","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro-oncol"},{"key":"R24-16-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.113.1.147","article-title":"Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin.","volume":"113","author":"Nehls","year":"1991","journal-title":"J Cell Biol"},{"key":"R25-16-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2004.12.005","article-title":"Cellular abnormalities of blood vessels as targets in cancer.","volume":"15","author":"Baluk","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"R26-16-20210130","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am J Pathol"},{"key":"R27-16-20210130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.","volume":"111","author":"Bergers","year":"2003","journal-title":"J Clin Invest"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200803001-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:00Z","timestamp":1786039020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200803001-00016"}},"subtitle":["Implications for Vessel Targeting Therapy"],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318150d6f0","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}